BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35901835)

  • 1. Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
    Lindsay HB; Massimino M; Avula S; Stivaros S; Grundy R; Metrock K; Bhatia A; Fernández-Teijeiro A; Chiapparini L; Bennett J; Wright K; Hoffman LM; Smith A; Pajtler KW; Poussaint TY; Warren KE; Foreman NK; Mirsky DM
    Lancet Oncol; 2022 Aug; 23(8):e393-e401. PubMed ID: 35901835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
    Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
    Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
    Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
    Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).
    Bhatia A; Sabin ND; Fisher MJ; Poussaint TY
    Pediatr Radiol; 2023 Dec; 53(13):2723-2741. PubMed ID: 37864711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
    Cooney TM; Cohen KJ; Guimaraes CV; Dhall G; Leach J; Massimino M; Erbetta A; Chiapparini L; Malbari F; Kramer K; Pollack IF; Baxter P; Laughlin S; Patay Z; Young Poussaint T; Warren KE
    Lancet Oncol; 2020 Jun; 21(6):e330-e336. PubMed ID: 32502459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAPNO efforts in Brain Tumour Outcomes.
    Virani QU; Javed Z; Shamim MS
    J Pak Med Assoc; 2024 May; 74(5):1005-1006. PubMed ID: 38783459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group.
    Warren KE; Poussaint TY; Vezina G; Hargrave D; Packer RJ; Goldman S; Wen PY; Pollack IF; Zurakowski D; Kun LE; Prados MD; Rutkowski S; Kieran MW
    Pediatr Blood Cancer; 2013 Sep; 60(9):1397-401. PubMed ID: 23625747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.
    Hoffman LM; Jaimes C; Mankad K; Mirsky DM; Tamrazi B; Tinkle CL; Kline C; Ramasubramanian A; Malbari F; Mangum R; Lindsay H; Horne V; Daniels DJ; Keole S; Grosshans DR; Young Poussaint T; Packer R; Cavalheiro S; Bison B; Hankinson TC; Müller HL; Bartels U; Warren KE; Chintagumpala M
    Neuro Oncol; 2023 Feb; 25(2):224-233. PubMed ID: 36124689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.
    Warren KE; Vezina G; Poussaint TY; Warmuth-Metz M; Chamberlain MC; Packer RJ; Brandes AA; Reiss M; Goldman S; Fisher MJ; Pollack IF; Prados MD; Wen PY; Chang SM; Dufour C; Zurakowski D; Kortmann RD; Kieran MW
    Neuro Oncol; 2018 Jan; 20(1):13-23. PubMed ID: 28449033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours.
    Avula S; Peet A; Morana G; Morgan P; Warmuth-Metz M; Jaspan T;
    Childs Nerv Syst; 2021 Aug; 37(8):2497-2508. PubMed ID: 33973057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group.
    Morana G; Shaw D; MacDonald SM; Alapetite C; Ajithkumar T; Bhatia A; Brisse H; Jaimes C; Czech T; Dhall G; Fangusaro J; Faure-Conter C; Fouladi M; Hargrave D; Harreld JH; Mitra D; Nicholson JC; Souweidane M; Timmermann B; Calaminus G; Bartels U; Bison B; Murray MJ
    Lancet Oncol; 2022 May; 23(5):e218-e228. PubMed ID: 35489353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response Assessment in Neuro-Oncology Clinical Trials.
    Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
    J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial ependymomas: The role of advanced neuroimaging in diagnosis and management.
    Varrassi M; Bellisari FC; De Donato MC; Tommasino E; Di Sibio A; Bruno F; Di Vitantonio H; Splendiani A; Di Cesare E; Masciocchi C
    Neuroradiol J; 2021 Apr; 34(2):80-92. PubMed ID: 33525963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
    Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
    Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Criteria in Neuro-oncology.
    Nowosielski M; Wen PY
    Semin Neurol; 2018 Feb; 38(1):24-31. PubMed ID: 29548049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapy and the evolving molecular landscape of paediatric ependymoma.
    Khatua S; Ramaswamy V; Bouffet E
    Eur J Cancer; 2017 Jan; 70():34-41. PubMed ID: 27866097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study.
    Merchant TE; Li C; Xiong X; Kun LE; Boop FA; Sanford RA
    Lancet Oncol; 2009 Mar; 10(3):258-66. PubMed ID: 19274783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1.
    D'Arco F; Culleton S; De Cocker LJL; Mankad K; Davila J; Tamrazi B
    Pediatr Radiol; 2018 Dec; 48(13):1833-1843. PubMed ID: 29980859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.
    Peng J; Zhou H; Tang O; Chang K; Wang P; Zeng X; Shen Q; Wu J; Xiao Y; Patel SH; Hu C; Jin K; Xiao B; Boxerman J; Gao X; Wen PY; Bai HX; Huang RY; Yang L
    Neuro Oncol; 2020 Oct; 22(10):1536-1544. PubMed ID: 32215549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Emerging Methods of Management of Ependymoma.
    Toescu SM; Aquilina K
    Curr Oncol Rep; 2019 Jul; 21(9):78. PubMed ID: 31359299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.